DIA provides the unique platform in the Middle East of connecting experts in the region for collaborative discussion.

Every country throughout the Middle East region is formulating improved regulations for pharmaceutical and biopharmaceutical development. What can we all learn from each other?

The 13th DIA Middle East Regulatory Conference (MERC), shaped in partnership with the EFPIA Middle East Regulatory Network (MERN), is built on the premise that collaboration leads to a more efficient regulatory system that sustains patient access to medicines. This conference, growing in scale every year, brings together health authorities and global stakeholders from across the region and Europe. The conference will discuss country-level progress and challenges, as well as opportunities for increased regional collaboration.

Are you ready to collaborate?

Top 3 Reasons to Attend the 2019 MERC:

1. Collaborate with Health Authorities from many different countries – Don’t miss this chance to get exposure to the future of health policy in the region
2. Connect with 300+ participants, representing 27 countries from health authorities and pharmaceutical industry, throughout the Middle East, Europe and globally
3. Establish leading strategies and processes for getting innovative medicines to patients faster

Who will you meet?

• Regulatory agencies and ministries of health in the region, experts from international organisations
• Thought leaders, global and local stakeholders from both local and multinational pharmaceutical companies who are working in the fields of
  • Regulatory affairs, Policy, Government Affairs, Access
  • Pharmacovigilance

To get a feel for the conference view the final programme from the 2017 MERC